This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
SoFi is betting big on product innovation to lift growth. This deep dive explains what the latest move could mean for...
As the calendar moves into spring, the housing market shows mixed signals. This spring housing market update explains...
Apple's latest price move spotlights a broader trend: AI-driven demand for memory chips. This piece explains how the ...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
Artificial intelligence is lifting power demand, pushing utilities to spend more on grids, storage, and data centers....
Tripadvisor (TRIP) entered 2026 with a clear path: optimize advertising, expand bookings, and monetize experiences. I...
OpenAI is stepping up its defense against prompt injection with a new AI red team. This shift could reshape how crypt...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
Bitcoin has quieted its swings, but risk-aware investors are still buying protection. This guide explains why hedges ...
Jack in the Box reported softer results in its latest quarter, bringing attention to jack box's revenue sales trends....
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...